Between a research request and a delivered cohort, the process can include six steps: feasibility, compliance review, IRB review or an exemption determination where the research requires it, pricing, chain-of-custody transfer, and delivery against acceptance criteria. Each step answers a different question. Is the material there? May it be used for this study? Under what terms? Can its handling be traced? Does it meet the request? Most delays come from the handoffs between these steps, not from the steps themselves.
What happens first after a cohort request is submitted?
The first step after a cohort request is feasibility. The supplier checks whether material matching the request exists and in what quantity. A feasibility count reports how many patients or specimens match the criteria at each site, before anyone commits to a study.
Feasibility often refines the request. A count may show that the stage criterion is achievable but the matched normal tissue is scarce. The researcher can then decide which criteria are essential. The guide to what to include in a biospecimen request covers how to separate required attributes from preferences.
What does compliance review check for a research cohort?
Compliance review for a research cohort checks that the material and data may be released for the stated use. The review covers several questions.
- Consent scope. Does the patient consent, or the applicable waiver, cover the intended research?
- HIPAA pathway. Will the data be de-identified, released as a limited data set under a data use agreement, or released under patient authorization or a waiver? A data use agreement is a contract that sets how a recipient may use a limited data set. The HHS overview of HIPAA and research describes these pathways.
- Institutional conditions. Does the holding institution require a material transfer agreement, a business associate agreement, or a review by its own committee?
Compliance review belongs to the institution that holds the material. The researcher’s role is to state the intended use clearly enough for that review to happen.
When does a research cohort need IRB review?
An institutional review board (IRB) is a committee that reviews research involving human subjects to protect the people whose information or tissue is used. Under the federal Common Rule, 45 CFR 46, a human subject is a living individual about whom an investigator conducting research either obtains information or biospecimens through intervention or interaction with the individual, and uses, studies, or analyzes them; or obtains, uses, studies, analyzes, or generates identifiable private information or identifiable biospecimens. Research covered by the Common Rule that involves human subjects needs IRB review or an exemption determination.
Research using only de-identified specimens and data may not meet that definition. The determination belongs to an IRB or the institution’s designated official, not to the buyer or the supplier alone. Expect to provide the study protocol and an approval, exemption, or not-human-subjects determination letter. The holding institution may also require its own review before release.
How is a research cohort priced?
A research cohort is priced on the work and material involved, not only the specimen count. Common cost drivers include:
- Retrieving blocks and slides from the archive.
- Sectioning, staining, or scanning.
- Abstracting and structuring clinical data.
- Review and agreement work at the holding institution.
- Packaging and shipping conditions.
A quote should state what it includes. In the Biobase model, partners recover their costs and share in the value their data creates, and suppliers are paid on delivery.
What is chain of custody for biospecimens?
Chain of custody for biospecimens is the documented record of who held a specimen, when, and in what condition, from retrieval to receipt. Each transfer records the sender, the recipient, the date, the shipping conditions, and the specimen identifiers on both sides.
Digital data needs the same record. For a dataset, the custody record shows who released it, who received it, when, and exactly which files or versions were transferred. Provenance complements that record: the source system, the transformations applied, and the de-identification steps. The NCI best practices for biospecimen resources cover specimen tracking and records management as core operational practices.
What does delivery of a research cohort include?
Delivery of a research cohort includes the material or data, the linked clinical information, and the records that show how both were handled. Physical delivery is specimens such as FFPE blocks or unstained slides. Digital delivery is a dataset such as whole-slide images with linked clinical fields.
The researcher checks the delivery against the acceptance criteria set in the request: quantity, format, required attributes, and documentation. Criteria agreed at intake make acceptance a check rather than a negotiation.
Why does running these steps in one flow shorten the path?
Running feasibility, review, pricing, and custody in one flow shortens the path because it removes handoffs. In a sequential process, each step starts when the previous one ends, often by email, and information is re-entered at every stage. A question at IRB review can send the request back to the start.
In one flow, the requirements captured at intake travel with the request into compliance review, pricing, and custody records. Steps that do not depend on each other can run at the same time. Questions surface while the request is still open.
Biobase runs governance, chain of custody, and pricing in one flow, and routes the request to IRB review where it applies. The IRB or the institution’s designated official makes that determination. Agents move the process forward, and people approve the consequential steps. Delivery is the fifth of the steps described in how a clinical archive becomes a research-ready cohort.
How can a researcher prepare?
A researcher can prepare by having these ready before the first request:
- The study protocol or a summary of the research question.
- The current IRB status: approved, exempt, pending, or not yet submitted.
- The acceptance criteria for material and data.
- The receiving organization and a contact who can resolve scientific questions.
Do not include patient identifiers in an initial request. Biobase’s request intake starts with the research requirements.